247 related articles for article (PubMed ID: 12912717)
1. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals.
Isetts BJ; Brown LM; Schondelmeyer SW; Lenarz LA
Arch Intern Med; 2003 Aug 11-25; 163(15):1813-20. PubMed ID: 12912717
[TBL] [Abstract][Full Text] [Related]
2. Effects of collaborative drug therapy management on patients' perceptions of care and health-related quality of life.
Isetts BJ; Schondelmeyer SW; Heaton AH; Wadd WB; Hardie NA; Artz MB
Res Social Adm Pharm; 2006 Mar; 2(1):129-42. PubMed ID: 17138505
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical care: pharmacy's mission for the 1990s.
Penna RP
Am J Hosp Pharm; 1990 Mar; 47(3):543-9. PubMed ID: 2316539
[TBL] [Abstract][Full Text] [Related]
4. Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory-care clinic.
Lobas NH; Lepinski PW; Abramowitz PW
Am J Hosp Pharm; 1992 Jul; 49(7):1681-8. PubMed ID: 1621723
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacy, pharmaceutical care, and the quality of drug therapy.
Hepler CD
Pharmacotherapy; 2004 Nov; 24(11):1491-8. PubMed ID: 15537552
[TBL] [Abstract][Full Text] [Related]
6. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
Sneed RC; May WL; Stencel C
Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
[TBL] [Abstract][Full Text] [Related]
7. Collaborative medication management in a team-based primary care practice: an explanatory conceptual framework.
Bajcar JM; Kennie N; Einarson TR
Res Social Adm Pharm; 2005 Sep; 1(3):408-29. PubMed ID: 17138487
[TBL] [Abstract][Full Text] [Related]
8. Assessing whether a clinical pharmacy program is meeting its goals.
Fink A; Kosecoff J; Oppenheimer PR; Smith WE; Brodie DC
Am J Hosp Pharm; 1982 May; 39(5):806-10. PubMed ID: 7081251
[TBL] [Abstract][Full Text] [Related]
9. Collaboration between pharmacists, physicians and nurse practitioners: a qualitative investigation of working relationships in the inpatient medical setting.
Makowsky MJ; Schindel TJ; Rosenthal M; Campbell K; Tsuyuki RT; Madill HM
J Interprof Care; 2009 Mar; 23(2):169-84. PubMed ID: 19234987
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting collaborative care between pharmacists and physicians.
Doucette WR; Nevins J; McDonough RP
Res Social Adm Pharm; 2005 Dec; 1(4):565-78. PubMed ID: 17138496
[TBL] [Abstract][Full Text] [Related]
11. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
12. [Newly-developed drug information services provided by hospital pharmacists].
Hirota Y
Rinsho Byori; 2003 Apr; 51(4):341-6. PubMed ID: 12747257
[TBL] [Abstract][Full Text] [Related]
13. The health care cost of drug-related morbidity and mortality in nursing facilities.
Bootman JL; Harrison DL; Cox E
Arch Intern Med; 1997 Oct; 157(18):2089-96. PubMed ID: 9382665
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of clinical pharmacists and physicians in the management of medication-related telephone calls in family practice offices.
Brown JM; Helling DK; Alexander MM; Burmeister LF
Am J Hosp Pharm; 1982 Mar; 39(3):437-43. PubMed ID: 7072728
[TBL] [Abstract][Full Text] [Related]
15. Physician-patient and pharmacist-patient communication: geriatrics' perceptions and opinions.
Keshishian F; Colodny N; Boone RT
Patient Educ Couns; 2008 May; 71(2):265-84. PubMed ID: 18308499
[TBL] [Abstract][Full Text] [Related]
16. Approaches to enhancing the quality of drug therapy. A joint statement by the CMA and the Canadian Pharmaceutical Association. Canadian Medical Association.
CMAJ; 1996 Sep; 155(6):784A-784F. PubMed ID: 8823225
[TBL] [Abstract][Full Text] [Related]
17. Provision of risk management and risk assessment information: the role of the pharmacist.
Schommer JC; Pedersen CA; Worley MM; Brown LM; Hadsall RS; Ranelli PL; Stratton TP; Uden DL; Chewning BA
Res Social Adm Pharm; 2006 Dec; 2(4):458-78. PubMed ID: 17161806
[TBL] [Abstract][Full Text] [Related]
18. Effects of pharmaceutical care intervention by clinical pharmacists in renal transplant clinics.
Wang HY; Chan AL; Chen MT; Liao CH; Tian YF
Transplant Proc; 2008 Sep; 40(7):2319-23. PubMed ID: 18790223
[TBL] [Abstract][Full Text] [Related]
19. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation.
Segal R; Grines LL; Pathak DS
Am J Hosp Pharm; 1988 Mar; 45(3):570-7. PubMed ID: 3369459
[TBL] [Abstract][Full Text] [Related]
20. Achieving cholesterol target in a managed care organization (ACTION) trial.
Straka RJ; Taheri R; Cooper SL; Smith JC
Pharmacotherapy; 2005 Mar; 25(3):360-71. PubMed ID: 15843283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
